Literature DB >> 25619611

Waterjet cutting of periprosthetic interface tissue in loosened hip prostheses: an in vitro feasibility study.

Gert Kraaij1, Gabrielle J M Tuijthof2, Jenny Dankelman3, Rob G H H Nelissen4, Edward R Valstar5.   

Abstract

Waterjet cutting technology is considered a promising technology to be used for minimally invasive removal of interface tissue surrounding aseptically loose hip prostheses. The goal of this study was to investigate the feasibility of waterjet cutting of interface tissue membrane. Waterjets with 0.2 mm and 0.6 mm diameter, a stand-off distance of 5 mm, and a traverse speed of 0.5 mm/s were used to cut interface tissue samples in half. The water flow through the nozzle was controlled by means of a valve. By changing the flow, the resulting waterjet pressure was regulated. Tissue sample thickness and the required waterjet pressures were measured. Mean thickness of the samples tested within the 0.2 mm nozzle group was 2.3 mm (SD 0.7 mm) and within the 0.6 mm nozzle group 2.6 mm (SD 0.9 mm). The required waterjet pressure to cut samples was between 10 and 12 MPa for the 0.2 mm nozzle and between 5 and 10 MPa for the 0.6 mm nozzle. Cutting bone or bone cement requires about 3 times higher waterjet pressure (30-50 MPa, depending on used nozzle diameter) and therefore we consider waterjet cutting as a safe technique to be used for minimally invasive interface tissue removal.
Copyright © 2015 IPEM. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hip prosthesis; Interface membrane; Loosening; Orthopedic surgery; Waterjet cutting

Mesh:

Substances:

Year:  2015        PMID: 25619611     DOI: 10.1016/j.medengphy.2014.12.009

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  1 in total

1.  Peri-prosthetic tissue cells show osteogenic capacity to differentiate into the osteoblastic lineage.

Authors:  Monique A E Schoeman; Angela E Oostlander; Karien Ede Rooij; Edward R Valstar; Rob G H H Nelissen
Journal:  J Orthop Res       Date:  2017-04-13       Impact factor: 3.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.